We use essential cookies (authentication, your saved goals/stack) by default. With your permission we'll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more
Head-to-head evidence comparison — which supplement is right for you?
CoQ10 and Niacin are closely matched across evidence, studies, and safety.
Verdict
Likely helps
16 of 20 studies with measurable effects showed benefit.
Top outcomes
Verdict
Probably helps
8 of 15 studies with measurable effects showed benefit.
Top outcomes
100-300mg daily
With fatty meal
Ubiquinol (reduced form)
500-2000mg daily for lipid effects; 50-500mg for general health
With food (reduces flush), Evening for lipid effects, Split doses for high amounts
Immediate-release niacin (nicotinic acid)
2-4 weeks
4-8 weeks
8-12 weeks
4-8 weeks
4-8 weeks
30-60 minutes after dose
Efficacy and Safety of Coenzyme Q10 Supplementation in the Treatment of Polycystic Ovary Syndrome: a Systematic Review and Meta-analysis
Reproductive sciences (Thousand Oaks, Calif.) (2023) · Meta analysis · n=1021
Only one RCT reported adverse events, and they found that patients had no adverse effects or symptoms following supplementation.
Coenzyme Q10 for heart failure
The Cochrane database of systematic reviews (2021) · Meta analysis · n=1573
Coenzyme Q10 probably reduces the risk of all-cause mortality more than control (RR 0.58, 95% CI 0.35 to 0.95; 1 study, 420 participants; number needed to treat for an additional beneficial outcome (NNTB) 13.3; moderate-quality evidence).
Antioxidants for female subfertility
The Cochrane database of systematic reviews (2017) · Meta analysis · n=6510
This suggests that among subfertile women with an expected clinical pregnancy rate of 22%, the rate among women using antioxidants would be between 27% and 33%.
Niacin for primary and secondary prevention of cardiovascular events
The Cochrane database of systematic reviews (2017) · Meta analysis · n=39195
Participants randomised to niacin were more likely to discontinue treatment due to side effects than participants randomised to control group (RR 2.17, 95% CI 1.70 to 2.77; participants = 33,539; studies = 17; I2 = 77%; moderate-quality evidence).
Effect of lipid-lowering therapies on lipoprotein(a) levels: a comprehensive meta-analysis of randomized controlled trials
Atherosclerosis (2025) · Meta analysis · n=145314
Among available LLTs, PCSK9mAbs, inclisiran, CETPi, and niacin significantly decreased Lp(a) levels.
A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk
Nature medicine (2024) · Meta analysis
Lastly, treatment with physiological levels of 4PY, but not its structural isomer 2PY, induced expression of VCAM-1 and leukocyte adherence to vascular endothelium in mice.
Based on heart failure meta-analysis (n=1573) showing mortality reduction. Effectiveness conservative due to single primary study (n=420). Take with food to reduce GI upset. Ubiquinol forms may have better absorption.
Based on multiple meta-analyses showing HDL increases. Higher doses increase discontinuation rates due to side effects (RR 2.17). Immediate-release forms have better lipid effects but more flushing.
AI-estimated from published studies. Interpret as directional guidance.
Both CoQ10 and Niacin are closely matched — the best choice depends on your specific health goals.
For reduce inflammation, Niacin has a higher relevance score (85 vs 55).
No known interactions between CoQ10 and Niacin have been documented in our database. However, always consult a healthcare provider before combining supplements.